A PHASE 1, RANDOMIZED, PARTICIPANT-AND INVESTIGATOR-BLINDED, PLACEBO-CONTROLLED STUDY TO EXPLORE THE SAFETY AND PHARMACOKINETICS OF SUPRATHERAPEUTIC MULTIPLE DOSES OF IPTACOPAN IN HEALTHY VOLUNTEERS

Authors
Category Primary study
Conference30th Congress of theEuropean Hematology Association Annual Congress, EHA2025
Year 2025
This article has no abstract
Epistemonikos ID: a03157c65e0d1b3f9eb6e1082104f85d10c93315
First added on: Nov 15, 2025